Skip to content. | Skip to navigation

Personal tools

Altaf Darvesh.jpg

Altaf Darvesh Ph.D.

Associate Professor of Pharmaceutical Sciences

Graduate Faculty Member College of Graduate Studies

Assistant Professor of Psychiatry

Pharmaceutical Sciences


Phone: (330)325-6658

Location: RGE-143


View Laboratory Website

Download Headshot

Altaf Darvesh, M.Pharm., Ph.D.

Assistant Professor of Pharmaceutical Sciences
Assistant Professor of Psychiatry, College of Medicine

Dr. Darvesh joined the Department of Pharmaceutical Sciences in October 2007. He received his B.Pharm. degree from Pune University, India in 1996 and his M.Pharm. degree in pharmacology from Bombay University, India in 1998. He then worked for a year as Clinical Research Associate at Pfizer (India) Ltd. In 2005, he received his Ph.D. degree in pharmaceutical sciences/pharmacology from the College of Pharmacy, University of Cincinnati, Ohio. He then worked for two years, initially as Post-Doctoral Fellow and later as Instructor at the Department of Psychiatry, Oregon Health and Science University, Portland, Oregon.


Teaching and Research Interests

His teaching interests include principles of drug action, receptor pharmacology, pharmacology of natural products, phytochemistry, neuropsychopharmacology, drugs of abuse and toxicology.

His research interests focus on studying the role of neurotoxicity, bioenergetic and oxidative stress in neurodegenerative diseases, and psychiatric illness. He is a member of several scientific organizations including Society for Neuroscience.


2005: Ph.D. in Pharmaceutical Sciences / Pharmacology, College of Pharmacy, University of Cincinnati, Cincinnati, OH

1998: M. Pharm. in Pharmacology, The Bombay College of Pharmacy, University of Mumbai, India

1996: B. Pharm., Nashik College of Pharmacy, University of Pune, India

Professional Experience

2008-present: Assistant Professor, Department of Psychiatry, Northeasthern Ohio Universities College of Medicine, Rootstown, OH

2007-present: Assistant Professor, Department of Pharmaceutical Sciences, Northeastern Ohio Universities College of Pharmacy, Rootstown, OH

2007-2007: Instructor, Department of Psychiatry, Oregon Health and Science University, Portland Veterans Affairs Research Center, Portland, OR

2005-2007: Post-doctoral fellow,Department of Psychiatry, Oregon Health and Science University (OHSU), Portland VA Medical Center, Portland, OR

1998-1999: Clinical Research Associate, Clinical Research Division, Pfizer Ltd., Mumbai, India

Research Interests

  • Development of neuroprotective strategies and elucidation of the role of oxidative stress and bioenergetic stress in neurodegenerative disorders such as Parkinson’s and Alzheimer’s disease as well as in psychiatric illnesses such as schizophrenia and posttraumatic stress disorder.

  • Elucidation of neurochemical mechanisms involved in neurotoxicity of amphetamines.
  • Mechanism of action of novel and atypical antipsychotics.
  • Preclinical studies utilize techniques such as microdialysis, HPLC, biochemical assays of neuronal metabolites, behavioral analysis in awake animals, immunohistochemistry, in situ hybridization, Western blots and Northern blots.

    Dr. Darvesh at work

Book Chapters

Bishayee A., and Darvesh A.S. Oxidative stress in cancer and neurodegenerative diseases: prevention and treatment by dietary antioxidants. In, Free Radicals: Formation, Types and Effects. Edited by: Kozyrev, D., Slutsky, V., Nova Science Publishers, Inc, Hauppauge, NY, 2010, 1-67.

Selected Publications

Click here for all publications via Google Scholar

Bishayee A, Bhatia D, Thoppil RJ, Darvesh AS, Nevo E, Lansky EP. “Pomegranate-mediated chemoprevention of experimental hepatocarcinogenesis involves Nrf2-regulated antioxidant mechanisms.” Carcinogenesis. 2011 Jun;32(6):888-96.

Mbimba, T., Awale, P., Bhatia, D., Geldenhuys, W.J., Darvesh, A.S., Carroll, R.T., Bishayee, A. Alteration of Hepatic Proinflammatory Cytokines is Involved in the Resveratrol-Mediated Chemoprevention of Chemically-Induced Hepatocarcinogenesis. Curr Pharm Biotechnol. -- in press (2011).

Geldenhuys, W.J., Bishayee, A., Darvesh, A.S., Carroll, R.T. Natural Products of Dietary Origin as Lead Compounds in Virtual Screening and Drug Design. Curr Pharm Biotechnol. -- in press (2011).

Darvesh, A.S., Aggarwal, B.B., Bishayee, A. Curcumin and Liver Cancer: A Review. Curr Pharm Biotechnol. -- in press (2011).

Bishayee, A., Bhatia, D., Darvesh, A.S., Nevo, E., Lansky, E.P. Pomegranate-mediated chemoprevention of experimental hepatocarcinogenesis involves Nrf2-regulated antioxidant mechanisms. Carcinogenesis – in press (2011).

Darvesh, A.S., Carroll, R.T., Geldenhuys, W.J., Gudelsky, G.A., Klein, J., Meshul, C.K., and Van der Schyf, C.J. In vivo brain microdialysis: advances in neuropsychopharmacoloy and drug discovery. Expert Opinion on Drug Discovery, 2011, 6, 109-127.

Bishayee, A., Háznagy-Radnai, E., Mbimba, T., Sipos, P., Morazzoni, P., Darvesh, A.S., Bhatia, D., and Hohmann, J. Anthocyanin-rich black currant extract suppresses the growth of human hepatocellular carcinoma cells. Natural Product Communications, in press (2010).

Bishayee, A., Waghray, A., Barnes, K.F., Mbimba, T., Bhatia, D., Chatterjee, M., Darvesh, A.S. Suppression of the inflammatory cascade is implicated in resveratrol chemoprevention of experimental hepatocarcinogenesis. Pharmaceutical Research-in press (2010).

Bishayee A., Barnes K.F., Bhatia D., Darvesh A.S., and Carroll R.T. Resveratrol suppresses oxidative stress and inflammatory response in diethylnitrosoamine- initiated rat hepatocarcinogenesis. Cancer Prev Res, 2010–in press.

Bishayee A., Politis T., and Darvesh A.S. Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma. Cancer Treat Rev, 2010; 36: 43-53.

Darvesh A.S., and Gudelsky G.A. Evidence for a role of energy dysregulation in the MDMA-induced depletion of brain 5-HT. Brain Res, 2005; 1056: 168-175.

Darvesh A.S., Yamamoto B.K. and Gudelsky G.A. Evidence for the involvement of nitric oxide in 3, 4-methylenedioxymethamphetamine-induced sertonin depletion in the rat brain. J Pharmacol Exp Ther, 2005; 312: 694-701.

Darvesh A.S., and Gudelsky G.A. The relationship between hyperthermia and glycogenolysis in 3, 4-methylenedioxymethamphetamine-induced serotonin depletion in rats. Neurotoxicol and Teratol, 2004; 26: 571-577.

Darvesh A.S., and Gudelsky G.A. Activation of 5-HT2 receptors induces glycogenolysis in the rat brain. Eur J Pharmacol, 2003; 464: 135-140.

Darvesh A.S., Shankaran M. and Gudelsky G.A. 3,4-methylenedioxymethamphetamine produces glycogenolysis and increases the extracellular concentration of glucose in the rat brain. J Pharmacol Exp Ther, 2002; 301: 138-144.

Darvesh A.S., Saraf, M.N. and Menon M.D. Toxicological evaluation of methacrylic acid copolymers synthesized by gamma radiation. Indian Drugs, 1999; 36: 220-224.

Darvesh A.S., Saraf, M.N. and Menon, M.D. Toxicological evaluation of film forming methacrylic acid copolymers. Indian J Pharm Sci, 1999; 61: 179-181.